eurofeedback as mental skill training for dysfunctional emotion regulatio
Not Applicable
Recruiting
- Conditions
- F60.3F32Emotionally unstable personality disorderDepressive episode
- Registration Number
- DRKS00029375
- Lead Sponsor
- Kinder- und JugendpsychiatrieEvangelisches Klinikum Bethel gGmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 21
Inclusion Criteria
Age 13-16 years
Dysfunctional emotion regulation (e.g. patients with disorder in the depressive spectrum or borderline personality disorder)
At least one non-suicide self-harm in the last year
Exclusion Criteria
No emotion dysregulation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pre-post-comparison regarding the following questions, measured with the help of targeted quesitonnaires as well as EEG:<br><br>(1) Does repeated training of the self-regulation ability of slow potentials (neurofeedback) lead to a change in executive functions?<br>(2) Does repeated training of the self-regulation ability of slow potentials (neurofeedback) lead to a change in emotional competence?<br>(3) Does repeated training of the self-regulation ability of slow potentials (neurofeedback) lead to a change in the frequency of occurrence of non-suicidal self-injurious behaviors?<br>(4) Does repeated training of the self-regulation ability of slow potentials (neurofeedback) lead to a change in the severity of symptoms in the presence of bipolar disorder?<br>(5) Does repeated training of the self-regulation ability of slow potentials (neurofeedback) lead to a change in the severity of symptoms in the presence of depression?
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie eurofeedback's impact on emotion regulation in F60.3 and F32 disorders?
How does eurofeedback compare to standard-of-care therapies for emotionally unstable personality disorder and depressive episodes?
Are there specific biomarkers that predict response to eurofeedback in patients with dysfunctional emotion regulation?
What adverse events are associated with eurofeedback interventions in psychiatric populations and how are they managed?
What are the potential combination approaches or alternative therapies for F60.3 and F32 disorders compared to eurofeedback?